In mammary tumors, for example, TAMs secrete epidermal growth factor receptor (EGFR) family ligands, including heparin-binding EGF-like growth factor (HB-EGF), and activate STAT3-related signaling pathways to fuel tumor cell proliferation (60). Here, HBEGF is linked to neoplasm.